Status:
UNKNOWN
Optimization of Hearing Performance in the Subject Implanted
Lead Sponsor:
University Hospital, Toulouse
Collaborating Sponsors:
Centre National de la Recherche Scientifique, France
Conditions:
Hearing Loss
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In the past two decades, the selection criteria for cochlear implantation have been greatly relaxed so that about 60-70% of present cochlear implant (CI) candidates have significant residual hearing i...
Eligibility Criteria
Inclusion
- Age\>18
- Unilaterally postlingually-deafened adult cochlear implanted candidates (IC-Uni)
- Person with almost normal or moderate contralateral hearing ( under 60dB)
- Cochlear implanted person whose activation has not yet been performed
- Cochlear implanted subjects with bilateral post-lingual profound deafness, who already benefit from a unilateral cochlear implant and candidates to a bilateral cochlear implant
- Affiliated to social security
Exclusion
- \- Subjects under juridical protections or tutelage measure
- Subjects with associated neurological or neurodegenerative conditions
- Significant anatomical changes on CT scan of the temporal bone that may interfere with the insertion of the cochlear implant
Key Trial Info
Start Date :
May 18 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 18 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05325450
Start Date
May 18 2023
End Date
January 18 2025
Last Update
August 24 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Marx
Toulouse, France